Detalhe da pesquisa
1.
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
Mol Cancer
; 21(1): 57, 2022 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35189910
2.
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.
Mol Cancer
; 19(1): 92, 2020 05 19.
Artigo
Inglês
| MEDLINE | ID: mdl-32430013
3.
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
Mol Cancer
; 19(1): 110, 2020 06 27.
Artigo
Inglês
| MEDLINE | ID: mdl-32593303
4.
The long noncoding RNA NORAD enhances the TGF-ß pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p.
J Cell Physiol
; 234(7): 12051-12060, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30537113
5.
Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.
Mol Cancer
; 23(1): 44, 2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38424621
6.
Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.
Mol Cancer
; 18(1): 105, 2019 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31153371
7.
Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression.
Cancer Sci
; 110(7): 2133-2144, 2019 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-31066149
8.
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors.
Liver Transpl
; 27(3): 444-449, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32897657
9.
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.
Nat Commun
; 15(1): 621, 2024 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38245530
10.
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis.
Cell Death Dis
; 14(2): 79, 2023 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36732324
11.
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion.
Hepatol Int
; 17(1): 63-76, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36418844
12.
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.
Signal Transduct Target Ther
; 8(1): 106, 2023 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36928584
13.
KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma.
Biomark Res
; 10(1): 25, 2022 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-35468812
14.
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.
J Hematol Oncol
; 14(1): 200, 2021 11 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34838121
15.
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Front Immunol
; 12: 705378, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34526987
16.
Overexpression of RNF38 facilitates TGF-ß signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.
J Exp Clin Cancer Res
; 38(1): 113, 2019 Mar 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30836988
17.
Downregulation of RNF128 activates Wnt/ß-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma.
J Hematol Oncol
; 12(1): 21, 2019 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30832692
18.
Mortalin stabilizes CD151-depedent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma.
J Cancer
; 10(25): 6199-6206, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31772652
19.
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors.
Theranostics
; 9(16): 4678-4687, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31367249
20.
Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
Cell Death Dis
; 8(12): 3205, 2017 12 13.
Artigo
Inglês
| MEDLINE | ID: mdl-29235470